PHARMACOKINETICS AND PHARMACODYNAMICS
Clinical trials for PHARMACOKINETICS AND PHARMACODYNAMICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS AND PHARMACODYNAMICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS AND PHARMACODYNAMICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New insulin aspart put to the test: will it match the original?
Knowledge-focused CompletedThis study compares a new rapid-acting insulin (UBLIN®) to the approved NovoRapid® in 44 healthy men. Each participant receives a single dose of both insulins on separate days to see how the body absorbs and responds. The goal is to check if the new insulin works similarly, which…
Matched conditions: PHARMACOKINETICS AND PHARMACODYNAMICS
Phase: NA • Sponsor: Zhuhai United Laboratories Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Study aims to Fine-Tune antibiotic dosing for ICU patients
Knowledge-focused CompletedThis study looks at how the antibiotic meropenem behaves in the blood of critically ill adults in the intensive care unit. Researchers compare different doses (1 gram vs. 2 grams) and infusion times (30 minutes vs. 3 hours) to see which keeps drug levels above the needed threshol…
Matched conditions: PHARMACOKINETICS AND PHARMACODYNAMICS
Phase: NA • Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New insulin vs. Brand-Name: a Head-to-Head test in healthy volunteers
Knowledge-focused CompletedThis trial tested how a new insulin injection (USLIN®R) compares to a standard brand (Novolin®R) in 32 healthy men. Each participant received both insulins at different times to measure how quickly and effectively they work. The goal is to see if the new insulin is similar enough…
Matched conditions: PHARMACOKINETICS AND PHARMACODYNAMICS
Phase: PHASE1 • Sponsor: Zhuhai United Laboratories Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Obesity and antibiotics: study seeks safer dosing
Knowledge-focused CompletedThis study looked at how to give the antibiotic vancomycin to obese adults. Researchers compared dosing based on weight versus kidney function to see which gives better drug levels. 35 healthy obese volunteers received a single dose and provided blood and urine samples. The goal …
Matched conditions: PHARMACOKINETICS AND PHARMACODYNAMICS
Phase: PHASE1 • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC